It is not difficult to see that the recruitment of death receptor signalling molecules such as CD95 to lipid rafts is a novel and promising mechanism in cancer therapy, as originally proposed and advanced by Mollinedo and Gajate's pioneering work.6, 9, 26. Here, FAS is linked to cancer.